PERRY A KARSEN Insider Trading $NTLA Intellia Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PERRY A KARSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PERRY A KARSEN. PERRY A KARSEN is see remarks in CELGENE CORP /DE/ ($CELG) and Senior Vice President in HUMAN GENOME SCIENCES INC ($HGSI) and Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and Director in OncoMed Pharmaceuticals Inc ($OMED) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Voyager Therapeutics, Inc. ($VYGR) and Director in Jounce Therapeutics, Inc. ($JNCE) and Director in Intellia Therapeutics, Inc. ($NTLA).
PERRY A KARSEN in Intellia Therapeutics, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of PERRY A KARSEN: Director
Holdings: 36,764 shares
Current Value: $488,961
Latest Transaction: Dec 18 2020
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PERRY A KARSEN in Intellia Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, CELG, HGSI, NTLA, JNCE, NAVB, OMED, VYGR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | M | 15.78 | 19,000 | 299,820 | 0 | |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | M | 25.98 | 19,000 | 493,620 | 0 | |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | M | 14.35 | 19,000 | 272,650 | 0 | |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | M | 18.00 | 31,764 | 571,752 | 0 | |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Sell | S | 54.33 | 21,336 | 1,159,185 | 5,000 | 26.3 K to 5 K (-81.01 %) |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Sell | S | 53.69 | 45,450 | 2,440,211 | 26,336 | 71.8 K to 26.3 K (-63.31 %) |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Sell | S | 52.52 | 21,978 | 1,154,285 | 71,786 | 93.8 K to 71.8 K (-23.44 %) |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Buy | M | 15.78 | 19,000 | 299,820 | 93,764 | 74.8 K to 93.8 K (+25.41 %) |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Buy | M | 25.98 | 19,000 | 493,620 | 74,764 | 55.8 K to 74.8 K (+34.07 %) |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Buy | M | 14.35 | 19,000 | 272,650 | 55,764 | 36.8 K to 55.8 K (+51.68 %) |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Buy | M | 18.00 | 31,764 | 571,752 | 36,764 | 5 K to 36.8 K (+635.28 %) |
| Jun 19 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | A | 20.72 | 19,000 | 393,680 | 19,000 | |
| May 21 2018 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | A | 25.98 | 19,000 | 493,620 | 19,000 | |
| Jun 05 2017 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Grant | A | 11.99 | 5,000 | 59,925 | 5,000 | 0 to 5 K |
| May 19 2017 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | A | 14.35 | 19,000 | 272,650 | 19,000 | |
| May 09 2016 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | A | 18.00 | 31,764 | 571,752 | 31,764 |
Page: 1